Domestic companies challenge inhaler market being monopolized by foreign ones
A series of domestic pharmaceutical companies have given prior notices to enter the inhaler market whose product dependency is mostly high on multinational companies.
Inhalers are usually launched by a small number of pharmaceutical companies – they are mostly multinational ones – due to the dif...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
